COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease

R Fernandez-Ruiz, JL Paredes, TB Niewold - Translational Research, 2021 - Elsevier
As the world navigates the coronavirus disease 2019 (COVID-19) pandemic, there is a
growing need to assess its impact in patients with autoimmune rheumatic diseases, such as …

COVID-19-related mortality in kidney transplant and haemodialysis patients: a comparative, prospective registry-based study

E Goffin, A Candellier, P Vart, M Noordzij… - Nephrology Dialysis …, 2021 - academic.oup.com
Abstract Background Coronavirus disease 2019 (COVID-19) has exposed haemodialysis
(HD) patients and kidney transplant (KT) recipients to an unprecedented life-threatening …

Characterization of the antispike IgG immune response to COVID-19 vaccines in people with a wide variety of immunodeficiencies

M Zendt, FA Bustos Carrillo, S Kelly, T Saturday… - Science …, 2023 - science.org
Research on coronavirus disease 2019 vaccination in immune-deficient/disordered people
(IDP) has focused on cancer and organ transplantation populations. In a prospective cohort …

Stratification of hospitalized COVID-19 patients into clinical severity progression groups by immuno-phenotyping and machine learning

YM Mueller, TJ Schrama, R Ruijten… - Nature …, 2022 - nature.com
Quantitative or qualitative differences in immunity may drive clinical severity in COVID-19.
Although longitudinal studies to record the course of immunological changes are ample …

Perspective of patients with autoimmune diseases on COVID-19 vaccination

L Boekel, F Hooijberg, ZLE van Kempen… - The Lancet …, 2021 - thelancet.com
The socioeconomic burden of COVID-19 and pressure on health-care systems can only be
reduced by achieving herd immunity against SARS-CoV-2. For herd immunity to be …

Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort …

H Bower, T Frisell, D Di Giuseppe… - Annals of the …, 2021 - ard.bmj.com
Objectives To estimate absolute and relative risks for all-cause mortality and for severe
COVID-19 in inflammatory joint diseases (IJDs) and with antirheumatic therapies. Methods …

COVID-19 and rheumatoid arthritis crosstalk: emerging association, therapeutic options and challenges

S Dewanjee, R Kandimalla, RS Kalra, C Valupadas… - Cells, 2021 - mdpi.com
Hyperactivation of immune responses resulting in excessive release of pro-inflammatory
mediators in alveoli/lung structures is the principal pathological feature of coronavirus …

COVID-19 in people living with HIV: a systematic review and meta-analysis

KW Lee, SF Yap, YF Ngeow, MS Lye - International journal of …, 2021 - mdpi.com
COVID-19 is a global health emergency. People living with human immunodeficiency virus
(PLHIV) have concerns about whether they have a higher risk of getting the infection and …

Clinical outcomes of COVID-19 in patients with rheumatic diseases: a systematic review and meta-analysis of global data

C Xu, Z Yi, R Cai, R Chen, BYH Thong, R Mu - Autoimmunity reviews, 2021 - Elsevier
Objectives The impact of rheumatic diseases on COVID-19 infection remains poorly
investigated. Here we performed a systematic review and meta-analysis to evaluate the …

High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV …

CDL Marques, AM Kakehasi, MM Pinheiro… - RMD open, 2021 - rmdopen.bmj.com
Objectives To evaluate risk factors associated with unfavourable outcomes: emergency care,
hospitalisation, admission to intensive care unit (ICU), mechanical ventilation and death in …